ORACEA® Capsules are the #1 prescribed oral rosacea brand among dermatologists
ORACEA Capsules are the only FDA-approved oral medication that treats the inflammatory lesions of rosacea from the inside. ORACEA Capsules substantially reduced both papules and pustules in as early as 3 weeks and did not induce bacterial resistance in a 9-month study.
The potent anti-inflammatory effect of doxycycline
The mechanism of action of ORACEA Capsules (30mg immediate release and 10 mg delayed-release doxycycline) in the treatment of inflammatory lesions of rosacea is unknown. In a clinical study, the effective formulation of ORACEA Capsules resulted in early and significant inflammatory lesion reduction.
ORACEA Capsules are precisely formulated to make a difference
The non-antibiotic dose, immediate- and delayed-release beads, is specifically engineered to remain below the antimicrobial threshold.